45 results on '"Hreinsson, Johann P."'
Search Results
2. Global Prevalence and Impact of Rumination Syndrome
3. Mo1425: COMORBID DISORDERS OF GUT-BRAIN INTERACTIONS IN INDIVIDUALS WITH SEVERE PSYCHOLOGICAL DISTRESS AND SOMATIC SYMPTOMS: RESULTS FROM A GLOBAL EPIDEMIOLOGY INTERNET STUDY
4. Tu1367: COMBINATIONS OF DEMOGRAHIC AND PSYCHOLOGICAL FACTORS, AND GASTROINTESTINAL AND SOMATIC SYMPTOMS ARE OF IMPORTANCE FOR DISEASE-SPECIFIC QUALITY OF LIFE IN IRRITABLE BOWEL SYNDROME
5. Mo1407: FACTOR ANALYSIS CONFIRMS GLOBAL VALIDITY OF ROME IV CRITERIA FOR MAJOR DISORDERS OF GUT-BRAIN INTERACTION (DGBI)
6. 533: THE LINK BETWEEN OROANAL TRANSIT, VISCERAL HYPERSENSITIVITY, GUT MICROBIAL FERMENTATION AND POSTPRANDIAL SYMPTOM RESPONSES IN IRRITABLE BOWEL SYNDROME
7. Tu1682 FOOD-INDUCED INTESTINAL MUCOSAL REACTIONS IN IRRITABLE BOWEL SYNDROME DETECTED WITH CONFOCAL LASER ENDOMICROSCOPY
8. Tu1376 PREDICTING MAJOR BLEEDING IN PATIENTS RECEIVING ANTICOAGULANT THERAPY – A NATIONWIDE OBSERVATIONAL STUDY
9. Tu1029 EFFECT OF MENOPAUSE AND MENSES ON GASTROINTESTINAL SYMPTOMS AMONG INDIVIDUALS WITH DGBI IN THE GLOBAL POPULATION
10. Mo1131 COMPARISION OF THE SEVERITY OF GASTROINTESTINAL BLEEDING AMONGST PATIENTS TREATED WITH WARFARIN AND DIRECT ORAL ANTICOAGULANTS
11. Mo1130 ICD-10 CODE VALIDATION FOR GASTROINTESTINAL BLEEDING IN PATIENTS RECEIVING ORAL ANTOCOAGULATION: NATIONWIDE STUDY
12. Mo1127 SEX DIFFERENCES IN GASTROINTESTINAL SYMPTOMS AND HEALTHCARE UTILIZATION AMONG INDIVIDUALS WITH DGBI IN THE GLOBAL POPULATION
13. Su1157 ORAL ANTICOAGULATION IS NOT ASSOCIATED WITH IMPROVED SURVIVAL IN PATIENTS DIAGNOSED WITH COLORECTAL CANCER - A 20-YEAR POPULATION-BASED STUDY.
14. Sa1160 LONG-TERM IMPACT OF LOW-DOSE ASPIRIN ON COLORECTAL CANCER SURVIVAL: A TWO-DECADE POPULATION-BASED ANALYSIS.
15. Sa1155 COMPARISON OF COLORECTAL CANCER IN PATIENTS OLDER AND YOUNGER THAN 50 YEARS OLD: A TWO-DECADE POPULATION-BASED STUDY.
16. Tu1644 LATENT CLASS MIXED MODELS: RESPONSES TO A LACTULOSE NUTRIENT CHALLENGE TEST IN PATIENTS WITH IRRITABLE BOWEL SYNDROME
17. Tu1624 EFFECTS OF CHANGES IN THE DIAGNOSTIC CRITERIA FOR IRRITABLE BOWEL SYNDROME (IBS) ON GLOBAL PREVALENCE RATES-RESULTS FROM THE ROME FOUNDATION GLOBAL EPIDEMIOLOGY STUDY
18. Tu1099 ORAL ANTICOAGULATION IS NOT ASSOCIATED WITH IMPROVED SURVIVAL IN PATIENTS WITH COLORECTAL CANCER
19. Mo1107 A COMPARATIVE STUDY OF DISORDERS OF GUT-BRAIN INTERACTION IN WESTERN EUROPE AND ASIA BASED ON THE ROME FOUNDATION GLOBAL EPIDEMIOLOGY STUDY
20. Mo1111 PREVALENCE AND IMPACT OF DISORDERS OF GUT-BRAIN INTERACTION (DGBI) IN THE SWEDISH GENERAL POPULATION
21. Sa1110 CLINICAL CHARACTERISTICS AND SURVIVAL BETWEEN PROXIMAL OR DISTAL COLORECTAL CANCER PATIENTS IN A NATIONWIDE COHORT
22. Tu1809 IS ORAL ANTICOAGULATION ASSOCIATED WITH IMPROVED SURVIVAL IN COLORECTAL CARCINOMA?
23. 339 WARFARIN IS ASSOCIATED WITH HIGHER RATES OF UPPER BUT NOT LOWER GASTROINTESTINAL BLEEDING COMPARED TO DIRECT ORAL ANTICOAGULANTS: A POPULATION-BASED PROPENSITY SCORE MATCHED COHORT STUDY
24. Mo1002 CAUSES OF LOWER GASTROINTESTINAL BLEEDING IN ORAL ANTICOAGULANT USERS COMPARED TO NON-USERS
25. Mo1001 CAUSES OF UPPER GASTROINTESTINAL BLEEDING IN ORAL ANTICOAGULANT USERS COMPARED TO NON-USERS
26. 326 – Rivaroxaban is Associated with Higher Rates of Gastrointestinal Bleeding Compared to Other Non-Vitamin K Anticoagulants: A Population-Based Propensity Scorematched Cohort Study
27. Mo1274 – Non-Vitamin K Oral Anticoagulants Have Lower Rates of Gastrointestinal Bleeding Compared to Warfarin: A Population-Based Propensity Score-Matched Cohort Study
28. Mo1252 – A Comparison of Logistic Regression and Gradient Boosting for Predicting Low-Risk Gastrointestinal Bleeding
29. Mo1181 - Acute Gastrointestinal Bleeding Among Patients on Antiplatelet and Anticoagulant Therapy after Percutaneous Coronary Intervention
30. Mo1167 - Incidence of Diverticular Bleeding: A Population-Based Study
31. Mo1161 - A Novel Risk Score for Assessing One-Year Mortality in Patients with Acute Lower Gastrointestinal Bleeding
32. Mo1166 - Risk Factors for 30-Day Re-Bleeding in Patients with Acute Lower Gastrointestinal Bleeding
33. A New Risk Score Aimed at Identifying Patients with Acute Lower Gastrointestinal Bleeding that do not Require Hospital-Based Intervention
34. Tu1370 The Rebleeding Rate of Patients With Acute Upper Gastrointestinal Bleeding in a Population-Based Setting During a 5 Year Follow-Up
35. Tu1373 Gastrointestinal Bleeding in Patients 80 Years and Older: Incidence, Association With Drugs and Prognosis
36. Mo1151 The Effect of Warfarin Use on the Prognosis of Colorectal Cancer Patients With Bleeding-Related Symptoms
37. Tu1076 the Rebleeding Rate of Patients With Acute Lower Gastrointestinal Bleeding in a Population-Based Setting During a 5 Year Follow-Up
38. Su1076 The Outcome and Role of Drugs in Patients With Unexplained Gastrointestinal Bleeding
39. Sa1009 - A New Risk Score Aimed at Identifying Patients with Acute Lower Gastrointestinal Bleeding that do not Require Hospital-Based Intervention
40. 175 The Association of Drugs and Specific Causes of Acute Lower Gastrointestinal Bleeding: a Prospective Study
41. Mo1969 The Incidence and Outcome of Ischemic Colitis in a Population Based Setting
42. Su1906 Acute Upper Gastrointestinal Bleeding in a Population-Based Setting: Incidence, Role of Drugs and Outcome
43. Tu1184 The Risk of Colorectal Cancer Is Not Increased in Patients After an Attack of Diverticulitis
44. Mo1008 Acute Lower Gastrointestinal Bleeding in a Population Based Setting: Incidence, Etiology and Outcomes
45. Sa1157 The Vast Majority of Patients With Colorectal Cancer Found on Colonoscopy Have Bleeding Related Symptoms at Presentation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.